Grantham, Mayo, Van Otterloo & Co (GMO)
NUS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Nu Skin NUS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,784
Closed -$328K – 742
2021
Q2 		$328K Sell
5,784
-100
-2% -$5.69K ﹤0.01% 658
2021
Q1 		$311K Sell
5,884
-752
-11% -$41K ﹤0.01% 777
2020
Q4 		$363K Sell
6,636
-36,064
-84% -$1.9M ﹤0.01% 724
2020
Q3 		$2.14M Buy
+42,700
New +$2.02M 0.02% 391
2014
Q3 		– Sell
-206,400
Closed -$15.3M – 468
2014
Q2 		$15.3M Buy
206,400
+90,000
+77% +$7.09M 0.04% 168
2014
Q1 		$9.64M Sell
116,400
-331,258
-74% -$29.1M 0.03% 212
2013
Q4 		$61.9M Buy
447,658
+433,789
+3,128% +$51.1M 0.15% 86
2013
Q3 		$1.33M Sell
13,869
-10,379
-43% -$881K ﹤0.01% 441
2013
Q2 		$1.48M Buy
+24,248
New +$1.35M ﹤0.01% 416

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NUS Position: Q3 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Nu Skin (NUS) in Q3 2021, closing a stake of 5,784 shares — an estimated $328K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NUS in Q2 2013 and held it in 9 quarters. The position peaked at $61.9M in Q4 2013. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Nu Skin position as of Q3 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,784 Nu Skin shares in Q3 2021, an estimated $328K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nu Skin in Q2 2013 and held it in 9 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nu Skin position peaked at $61.9M in Q4 2013.
  • 246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.